Dec 2, 2025 by Lee SamahaCan UPS Stock Beat the Market?The package delivery faces near-term pressure, but its yield is massive, and management's operational strategy makes sense.
Dec 2, 2025 by Danny Vena, CPAMongoDB Just Surged to a New 52-Week High. Is This the Turnaround Investors Have Been Waiting For?The cloud-native database provider is benefiting from surging demand for artificial intelligence (AI).
Dec 2, 2025 by Geoffrey Seiler2 Ultra-High-Yield Pipeline Stocks to Buy With $10,000 and Hold ForeverEnergy Transfer and Western Midstream have high yields and growing distributions.
Dec 2, 2025 by Adria CiminoHere's Why Nvidia Still is a Multimillionaire-MakerThe company plays a key role in the AI boom.
Dec 2, 2025 by Lee SamahaCan UPS Stock Beat the Market?The package delivery faces near-term pressure, but its yield is massive, and management's operational strategy makes sense.
Dec 2, 2025 by Katie BrockmanIs Warren Buffett Sending a Quiet Warning to Investors? Here's What You Need to Know.Berkshire Hathaway's cash stockpile just reached record heights. Is that a warning sign for investors?
Dec 2, 2025 by Jonathan PoncianoDescartes Stock Down 29% in a Year — Is That Why a Major Investor Just Cut Its Stake?Descartes’ steady financial results weren’t enough to keep one major investor from cutting back—here’s what the move signals.
Dec 2, 2025 by Eric VolkmanWhy Vera Therapeutics Stock Rocked the Market on TuesdayA competitor recently earned FDA approval, but this drug is reportedly going to be pricey.
Dec 2, 2025 by Eric VolkmanWhy Beta Technologies Stock Rocketed 8% Higher on TuesdayThe company signed a supply arrangement that might last for a decade.
Dec 2, 2025 by Motley Fool YouTubeCadence Design Systems: A Stock Worth Watching in 2025?Could Cadence Design Systems be the next big opportunity for investors? Tune in as our experts break down the stock's potential and risks in this insightful analysis.
Dec 2, 2025 by Eric VolkmanWhy Iren Stock Plummeted TodayInvestors were concerned about how the company's latest financing move would impact its fundamentals and stock.
Dec 2, 2025 by Jeff SantoroIYK vs. XLP: Top Holdings Could Make the DifferenceExplore how two leading consumer staples ETFs differ in sector reach, portfolio makeup, and what that means for diversified exposure.
Dec 2, 2025 by Joe TenebrusoWhy Credo Stock Jumped TodayThe connectivity solutions specialist's customers have a need for speed.
Dec 2, 2025 by Eric VolkmanWhy GE Venova Stock Topped the Market on TuesdayThe company's joint venture received a major boost for its Tennessee nuclear power facility.
Dec 2, 2025 by Josh Kohn-LindquistCEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too?Is the CEO's latest purchase a buy signal for investors?
Dec 2, 2025 by Chris MacDonald3 Reasons Why Bitcoin Surged 6% to Break Back Through the $90,000 LevelBitcoin's ascent has been impressive, and it may be far from over.
Dec 2, 2025 by Eric VolkmanWhy Clean Harbors Stock Triumphed on TuesdayThe company secured additional work from an existing client with deep pockets.
Dec 2, 2025 by Jonathan PoncianoRare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You?PTC’s strong third quarter and breakout Sephience launch may help explain why one life-sciences fund is quietly upping its bet.
Dec 2, 2025 by Jonathan PoncianoCelcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping InA top biotech fund just made a bold move while Celcuity trades near record highs—here’s what they might see coming next.
Dec 2, 2025 by Johnny RiceWhy Intel Stock Soared 8.7% TodayThe ailing chipmaker may have a new contract.
Dec 2, 2025 by Joe TenebrusoWhy MongoDB Stock Surged TodayNew CEO CJ Desai sees an artificial intelligence (AI)-driven "opportunity that comes once in a lifetime."
Dec 2, 2025 by Jonathan PoncianoPrecigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.
Dec 2, 2025 by Jonathan PoncianoAurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?A top life sciences investor is doubling down as Aurinia’s flagship therapy gains momentum—here’s what long-term shareholders should watch next.
